Heparan sulfate/heparin promotes transthyretin fibrillization through selective binding to a basic motif in the protein-Reference-Cited by-同舟云学术

Heparan sulfate/heparin promotes transthyretin fibrillization through selective binding to a basic motif in the protein

Published:2011-03-21 Issue:14 Volume:108 Page:5584-5589
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Noborn F.,O'Callaghan P.,Hermansson E.,Zhang X.,Ancsin J. B.,Damas A. M.,Dacklin I.,Presto J.,Johansson J.,Saraiva M. J.,Lundgren E.,Kisilevsky R.,Westermark P.,Li J.-P.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference36 articles.

1. Structure of prealbumin: Secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 Å

2. Evolutionary changes to transthyretin: structure-function relationships

3. Studies on the Protein-Protein and Protein-Ligand Interactions Involved in Retinol Transport in Plasma

4. Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin).

5. Cardiac Amyloidosis: Report of a Patient Heterozygous for the Transthyretin Isoleucine 122 Variant

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A charged tail on anti-α-Synuclein antibodies does not enhance their affinity to α-Synuclein fibrils;PLOS ONE;2024-08-29

2. Heparan sulfate proteoglycans: Mediators of cellular and molecular Alzheimer's disease pathogenic factors via tunnelling nanotubes?;Molecular and Cellular Neuroscience;2024-06

3. Degradation versus fibrillogenesis, two alternative pathways modulated by seeds and glycosaminoglycans;Protein Science;2024-02-21

4. Targeted sequencing of selected functional genes in patients with wild-type transthyretin amyloidosis;BMC Research Notes;2023-10-02

5. Cellular environment of TTR deposits in an animal model of ATTR—Cardiomyopathy;Frontiers in Molecular Biosciences;2023-03-08